For labeling neuronal nuclei, PrimeFlow labeling kit (ThermoFisher, #88-18005-210) was used and fixation and permeabilization were carried out according to manufacturer’s instructions but with 200 U ml−1 Superase-In RNase inhibitor and 400 U ml−1 RNasin ribonuclease inhibitor present at every incubation step. For sorting, the nuclei were resuspended in sorting buffer (PBS, 0.2% BSA, 40 U ml−1 RNasin ribonuclease inhibitor, 0.5 µg ml−1 DAPI). Probes specific to DRD1 (Alexa-647, #VA1-3002351-PF), DRD2 (Alexa-488, #VA4-3083767-PF) and PPP1R1B (Alexa-568, #VA10-3266354-PF) were used to label dMSN (647+, 568+, 488−, large) and iMSN nuclei (647−, 568+, 488+, large). In a separate set of experiments, probes specific to TAC3 (Alexa-647, #VA1-16603-PF), ETV1 (Alexa-488, # VA4-3083818-PF), SST (Alexa-568, # VA10-3252595-PF) and PPP1R1B (Alexa-568, # VA10-3266354-PF) were used to label the nuclei of TAC3+ interneurons (647+, 568−, 488+), PVALB+ interneurons (647−, 568−, 488+), SST+ interneurons (647−, 568+++, 488−) and MSNs (647−, 568+, 488−, large). Probes specific to TRPC3 (Alexa-647, # VA1-3004835-PF), COL6A6 (Alexa-647, #VA1-3014134-PF) and PPP1R1B (Alexa-568, # VA10-3266354-PF) were used in another set of experiments to label cholinergic interneuron nuclei (647+, 568−, large) and MSN nuclei (647−, 568+, large). CA8 probe (Alexa-647, #VA1-3001892-PF) was used for sorting Purkinje neuron nuclei (647+, large). Aggregates of nuclei were always excluded based on higher intensity of DAPI staining. All PrimeFlow target probes were used at a dilution of 1:40.
Nuclei Isolation and Labeling for Cell-Type Specific Profiling
For labeling neuronal nuclei, PrimeFlow labeling kit (ThermoFisher, #88-18005-210) was used and fixation and permeabilization were carried out according to manufacturer’s instructions but with 200 U ml−1 Superase-In RNase inhibitor and 400 U ml−1 RNasin ribonuclease inhibitor present at every incubation step. For sorting, the nuclei were resuspended in sorting buffer (PBS, 0.2% BSA, 40 U ml−1 RNasin ribonuclease inhibitor, 0.5 µg ml−1 DAPI). Probes specific to DRD1 (Alexa-647, #VA1-3002351-PF), DRD2 (Alexa-488, #VA4-3083767-PF) and PPP1R1B (Alexa-568, #VA10-3266354-PF) were used to label dMSN (647+, 568+, 488−, large) and iMSN nuclei (647−, 568+, 488+, large). In a separate set of experiments, probes specific to TAC3 (Alexa-647, #VA1-16603-PF), ETV1 (Alexa-488, # VA4-3083818-PF), SST (Alexa-568, # VA10-3252595-PF) and PPP1R1B (Alexa-568, # VA10-3266354-PF) were used to label the nuclei of TAC3+ interneurons (647+, 568−, 488+), PVALB+ interneurons (647−, 568−, 488+), SST+ interneurons (647−, 568+++, 488−) and MSNs (647−, 568+, 488−, large). Probes specific to TRPC3 (Alexa-647, # VA1-3004835-PF), COL6A6 (Alexa-647, #VA1-3014134-PF) and PPP1R1B (Alexa-568, # VA10-3266354-PF) were used in another set of experiments to label cholinergic interneuron nuclei (647+, 568−, large) and MSN nuclei (647−, 568+, large). CA8 probe (Alexa-647, #VA1-3001892-PF) was used for sorting Purkinje neuron nuclei (647+, large). Aggregates of nuclei were always excluded based on higher intensity of DAPI staining. All PrimeFlow target probes were used at a dilution of 1:40.
Corresponding Organization :
Other organizations : Rockefeller University, Hospital for Sick Children, University of Miami, Université Laval, University of Toronto
Variable analysis
- Labeling of glial cell nuclei and cerebellar granule cells
- Labeling of neuronal nuclei using PrimeFlow labeling kit
- Sorting of neuronal nuclei (647+, 594+, 488−, large)
- Sorting of oligodendrocyte nuclei (647+, 594−, 488−, small)
- Sorting of microglia nuclei (647−, 594+, 488−, small)
- Sorting of astrocyte nuclei (647−, 594−, 488+, small)
- Sorting of cerebellar granule cell nuclei (488−, 594+)
- Sorting of dMSN nuclei (647+, 568+, 488−, large)
- Sorting of iMSN nuclei (647−, 568+, 488+, large)
- Sorting of TAC3+ interneuron nuclei (647+, 568−, 488+)
- Sorting of PVALB+ interneuron nuclei (647−, 568−, 488+)
- Sorting of SST+ interneuron nuclei (647−, 568+++, 488−)
- Sorting of cholinergic interneuron nuclei (647+, 568−, large)
- Sorting of Purkinje neuron nuclei (647+, large)
- Homogenization buffer (0.25 M sucrose, 150 mM KCl, 5 mM MgCl2, 20 mM Tricine pH 7.8, 0.15 mM spermine, 0.5 mM spermidine, EDTA-free protease inhibitor cocktail, 1 mM DTT, 20 U ml−1 SUPERase-In RNase inhibitor, 40 U ml−1 RNasin ribonuclease inhibitor)
- Wash buffer (PBS, 0.05% TritonX-100, 0.5% BSA, 20 U ml−1 Superase-In RNase Inhibitor and 40 U ml−1 RNasin ribonuclease inhibitor)
- Sorting buffer (PBS, 0.2% BSA, 40 U ml−1 RNasin ribonuclease inhibitor, 0.5 µg ml−1 DAPI)
- Centrifugation conditions (1,000 × g, 4 min, 4 °C)
- Fixation with 1% formaldehyde for 8 min at room temperature
- Quenching with 0.125 M glycine for 5 min
- Incubation of nuclei overnight at 4 °C with antibodies
- Incubation of nuclei for 30-45 min at room temperature with secondary antibodies
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!